EUVIMEDEUVIMED entdecken
Crossref

Proton Beam Radiation Therapy (PBRT): Evidence-Based Indications, Emerging Innovations, and Future Research Priorities

Vijay Sharma, Gyanendra Kumar Sharma, Maneesh Kumar Singh, Shiva Teotia, Siddharth Dhaka, Navneet Verma, Saurabh Sharma, Amit Kumar

International Journal of Drug Delivery Technology · 04.06.2026 · 16 (46s)

DOI: 10.25258/ijddt.16.46s.31 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 04.06.2026. Verfasst von Vijay Sharma und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proton therapy is a modern breakthrough in radiation oncology. It provides a more accurate alternative to conventional radiation radiotherapy with the use of photons. Proton therapy differs with the other conventional ways of radiations in that it concentrates high radiation on the tumor and the normal tissues around the tumor are not exposed to significant amounts of radiation as in the other methods. Such a strategy will minimize contact with surrounding healthy tissues. Bragg peak phenomenon renders proton therapy to have a clinical advantage. Protons also shed off the majority of their energy at a particular depth within the tumor in this process. This is because it leaves a low dose outside the target. This property enables a much safer protection of normal tissues, which reduces adverse effects of the treatment, as well as ensuring the protection of other vital organs. This review summarizes the physical principles, technological developments and clinical applications of proton therapy, with particular focus on pediatric cancers, tumors of the brain and spinal cord, head and neck malignancies, prostate cancer and ocular tumors. Evidence from clinical studies regarding tumor control, survival outcomes and toxicity profiles is discussed. Although high cost and limited availability remain challenges, continued technological innovation and expanding clinical experience are expected to enhance the role of proton therapy in contemporary cancer care

Zitieren

APA

Sharma, V., Sharma, G. K., Singh, M. K., Teotia, S., Dhaka, S., Verma, N., Sharma, S., & Kumar, A. (2026). Proton Beam Radiation Therapy (PBRT): Evidence-Based Indications, Emerging Innovations, and Future Research Priorities. International Journal of Drug Delivery Technology, 16(46s). https://doi.org/10.25258/ijddt.16.46s.31

Vancouver

Sharma V, Sharma GK, Singh MK, Teotia S, Dhaka S, Verma N, et al. Proton Beam Radiation Therapy (PBRT): Evidence-Based Indications, Emerging Innovations, and Future Research Priorities. International Journal of Drug Delivery Technology. 2026;16(46s). doi:10.25258/ijddt.16.46s.31

BibTeX
@article{Sharma2026,
  author = {Sharma, Vijay and Sharma, Gyanendra Kumar and Singh, Maneesh Kumar and Teotia, Shiva and Dhaka, Siddharth and Verma, Navneet and Sharma, Saurabh and Kumar, Amit},
  title = {Proton Beam Radiation Therapy (PBRT): Evidence-Based Indications, Emerging Innovations, and Future Research Priorities},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {46s},
  doi = {10.25258/ijddt.16.46s.31}
}
Kostenlos starten →